Seeing Is Believing

Currently out of the existing stock ratings of Marie Thibault, 121 are a BUY (92.37%), 10 are a HOLD (7.63%).
Analyst Marie Thibault, currently employed at BTIG, carries an average stock price target met ratio of 50.01% that have a potential upside of 31.21% achieved within 124 days.
Marie Thibault’s has documented 258 price targets and ratings displayed on 24 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BSX, Boston Scientific Corp at 21-Oct-2025.
Analyst best performing recommendations are on STIM (NEURONETICS).
The best stock recommendation documented was for STIM (NEURONETICS) at 1/21/2021. The price target of $21 was fulfilled within 1 day with a profit of $2.58 (14.01%) receiving and performance score of 140.07.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$162
$35.15 (27.71%)
$159
14 days ago
(16-Oct-2025)
18/25 (72%)
$33.46 (26.03%)
499
Buy
$142
$15.15 (11.94%)
$144
15 days ago
(15-Oct-2025)
7/11 (63.64%)
$14.37 (11.26%)
317
Buy
$146
$19.15 (15.10%)
$141
15 days ago
(15-Oct-2025)
18/23 (78.26%)
$18.37 (14.39%)
376
Buy
$145
$18.15 (14.31%)
$137
3 months 13 days ago
(17-Jul-2025)
13/14 (92.86%)
$21.33 (17.25%)
369
Buy
$145
$18.15 (14.31%)
$139
3 months 13 days ago
(17-Jul-2025)
6/9 (66.67%)
$21.33 (17.25%)
753
Which stock is Marie Thibault is most bullish on?
Which stock is Marie Thibault is most reserved on?
What Year was the first public recommendation made by Marie Thibault?